concentrix corp - CNXC

CNXC

Close Chg Chg %
41.42 0.76 1.83%

Closed Market

42.18

+0.76 (1.83%)

Volume: 1.26M

Last Updated:

Jan 15, 2026, 4:00 PM EDT

Company Overview: concentrix corp - CNXC

CNXC Key Data

Open

$41.34

Day Range

40.93 - 43.16

52 Week Range

31.63 - 66.00

Market Cap

$2.58B

Shares Outstanding

62.26M

Public Float

43.53M

Beta

0.48

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$20.82

Yield

346.67%

Dividend

$0.36

EX-DIVIDEND DATE

Jan 30, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

1.05M

 

CNXC Performance

1 Week
 
-5.99%
 
1 Month
 
4.68%
 
3 Months
 
-7.65%
 
1 Year
 
-15.40%
 
5 Years
 
-65.55%
 

CNXC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4
Full Ratings ➔

About concentrix corp - CNXC

Concentrix Corp. engages in the provision of customer experience solutions and technology. The company was founded in 1973 and is headquartered in Newark, CA.

CNXC At a Glance

Concentrix Corp.
39899 Balentine Drive
Newark, California 94560
Phone 1-800-747-0583 Revenue 9.83B
Industry Information Technology Services Net Income -1,278,924,000.00
Sector Technology Services 2025 Sales Growth 2.151%
Fiscal Year-end 11 / 2026 Employees N/A
View SEC Filings

CNXC Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.232
Price to Book Ratio 0.815
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA 5.234
Enterprise Value to Sales 0.671
Total Debt to Enterprise Value 0.704

CNXC Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 4.915
Total Asset Turnover 0.864

CNXC Liquidity

Current Ratio 1.404
Quick Ratio N/A
Cash Ratio 0.149

CNXC Profitability

Gross Margin 28.343
Operating Margin 6.204
Pretax Margin -12.032
Net Margin -13.016
Return on Assets -11.242
Return on Equity -37.704
Return on Total Capital -17.323
Return on Invested Capital -15.302

CNXC Capital Structure

Total Debt to Total Equity 169.021
Total Debt to Total Capital 62.828
Total Debt to Total Assets 43.105
Long-Term Debt to Equity 166.63
Long-Term Debt to Total Capital 61.939
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Concentrix Corp - CNXC

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
6.32B 7.11B 9.62B 9.83B
Sales Growth
+13.20% +12.49% +35.20% +2.15%
Cost of Goods Sold (COGS) incl D&A
4.35B 4.91B 6.87B 7.04B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
309.54M 388.30M 705.85M 650.11M
Depreciation
146.86M 173.46M 246.92M 215.78M
Amortization of Intangibles
162.67M 214.83M 458.93M 434.33M
COGS Growth
+11.05% +12.94% +39.92% +2.46%
Gross Income
1.98B 2.20B 2.75B 2.78B
Gross Income Growth
+18.23% +11.51% +24.68% +1.38%
Gross Profit Margin
+31.24% +30.97% +28.56% +28.34%
2022 2023 2024 2025 5-year trend
SG&A Expense
1.27B 1.45B 1.99B 2.18B
Research & Development
- - - -
-
Other SG&A
1.27B 1.45B 1.99B 2.18B
SGA Growth
+10.85% +14.74% +36.96% +9.37%
Other Operating Expense
- - - -
-
Unusual Expense
91.75M 154.84M 117.56M 1.53B
EBIT after Unusual Expense
618.44M 596.21M 640.48M (916.23M)
Non Operating Income/Expense
56.64M (12.54M) (19.38M) 24.35M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
70.08M 175.45M 321.83M 290.35M
Interest Expense Growth
+204.07% +150.37% +83.43% -9.78%
Gross Interest Expense
70.08M 175.45M 321.83M 290.35M
Interest Capitalized
- - - -
-
Pretax Income
605.00M 408.23M 299.27M (1.18B)
Pretax Income Growth
+8.87% -32.52% -26.69% -495.03%
Pretax Margin
+9.57% +5.74% +3.11% -12.03%
Income Tax
169.36M 94.39M 48.06M 96.70M
Income Tax - Current - Domestic
- 70.57M 90.03M 97.72M
Income Tax - Current - Foreign
- 129.61M 126.07M 185.58M
Income Tax - Deferred - Domestic
- (31.90M) (110.22M) (124.70M)
Income Tax - Deferred - Foreign
- 1.07M (11.49M) (110.55M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- (6.63M) (6.00M) (9.50M)
Consolidated Net Income
429.01M 307.84M 241.71M (1.28B)
Minority Interest Expense
- - - 591.00K
-
Net Income
428.42M 307.84M 241.71M (1.28B)
Net Income Growth
+7.16% -28.14% -21.48% -629.11%
Net Margin Growth
+6.77% +4.33% +2.51% -13.02%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
428.42M 307.84M 241.71M (1.28B)
Preferred Dividends
- - - -
-
Net Income Available to Common
428.42M 307.84M 241.71M (1.28B)
EPS (Basic)
8.3426 5.7218 3.72 -20.2965
EPS (Basic) Growth
+7.16% -31.41% -34.99% -645.60%
Basic Shares Outstanding
51.35M 53.80M 64.98M 63.01M
EPS (Diluted)
8.2811 5.7001 3.7146 -20.36
EPS (Diluted) Growth
+7.52% -31.17% -34.83% -648.11%
Diluted Shares Outstanding
51.74M 54.01M 65.07M 63.01M
EBITDA
1.02B 1.14B 1.46B 1.26B
EBITDA Growth
+26.42% +11.73% +28.49% -13.95%
EBITDA Margin
+16.12% +16.01% +15.22% +12.82%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 65.00
Number of Ratings 4 Current Quarters Estimate 2.645
FY Report Date 02 / 2026 Current Year's Estimate 11.865
Last Quarter’s Earnings 2.95 Median PE on CY Estimate N/A
Year Ago Earnings 11.22 Next Fiscal Year Estimate 13.125
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 4 4 4
Mean Estimate 2.65 2.76 11.87 13.13
High Estimates 2.66 2.84 12.04 13.84
Low Estimate 2.63 2.68 11.74 12.51
Coefficient of Variance 0.49 2.48 1.14 4.32

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 3 3
OVERWEIGHT 1 1 1
HOLD 1 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Concentrix Corp - CNXC

Date Name Shares Transaction Value
Dec 4, 2025 Christopher A. Caldwell President and CEO; Director 280,586 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $36.52 per share 10,247,000.72
Dec 3, 2025 Cormac Twomey EVP, Global Ops & Delivery 35,130 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $35.5 per share 1,247,115.00
Apr 18, 2025 Olivier Fabrice Duha Director 292,360 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50.08 per share 14,641,388.80
Apr 18, 2025 Olivier Fabrice Duha Director 280,721 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.19 per share 13,527,944.99
Apr 18, 2025 Olivier Fabrice Duha Director 292,588 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $49.46 per share 14,471,402.48
Apr 18, 2025 Olivier Fabrice Duha Director 299,042 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.24 per share 14,425,786.08
Apr 18, 2025 Olivier Fabrice Duha Director 9,499 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.21 per share 457,946.79
Apr 18, 2025 Olivier Fabrice Duha Director 16,675 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $49.42 per share 824,078.50
Apr 18, 2025 Olivier Fabrice Duha Director 23,568 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.3 per share 1,138,334.40
Apr 18, 2025 Olivier Fabrice Duha Director 1,144,350 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.2 per share 55,157,670.00
Apr 18, 2025 Olivier Fabrice Duha Director 1,155,862 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $49.45 per share 57,157,375.90
Apr 18, 2025 Olivier Fabrice Duha Director 1,162,570 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.25 per share 56,094,002.50
Mar 28, 2025 Ann F. Vezina Director 11,947 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Kathryn V. Marinello Director 10,003 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Nicolas Joseph Michel Gheysens Director 7,826 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Kathryn J. Hayley Director 10,011 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Jennifer Deason Director 10,003 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Te Chien Chou Director 306 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 LaVerne H. Council Director 10,003 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Dennis J. Polk Director 21,223 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Concentrix Corp in the News